(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 26.12%173.21B | 20.13%119.5B | 12.61%69.97B | -13.63%29.04B | 0.69%137.34B | 9.56%99.48B | 0.33%62.13B | 8.04%33.62B | 32.04%136.4B | 46.11%90.8B |
Operating income | 26.12%173.21B | 20.13%119.5B | 12.61%69.97B | -13.63%29.04B | 0.69%137.34B | 9.56%99.48B | 0.33%62.13B | 8.04%33.62B | 32.04%136.4B | 46.11%90.8B |
Operating expenses | -27.12%-140.77B | -21.74%-96.98B | -14.72%-58.18B | 12.47%-24.37B | 3.17%-110.74B | -5.19%-79.67B | 2.22%-50.71B | -5.43%-27.84B | -33.71%-114.37B | -45.98%-75.74B |
Gross profit | 21.95%32.44B | 13.66%22.52B | 3.24%11.79B | -19.21%4.67B | 20.71%26.6B | 31.57%19.81B | 13.48%11.42B | 22.72%5.78B | 23.97%22.04B | 46.77%15.06B |
Selling expenses | -41.00%-8.29B | -32.53%-5.11B | -46.80%-3.25B | -38.31%-1.45B | -13.17%-5.88B | 1.39%-3.85B | 9.34%-2.22B | 8.09%-1.05B | -26.53%-5.19B | -71.02%-3.91B |
Administrative expenses | 3.24%-4.74B | 10.61%-3.09B | 6.43%-2.07B | 9.97%-1.06B | -21.03%-4.89B | -43.33%-3.46B | -65.03%-2.21B | -77.51%-1.18B | -58.39%-4.04B | -59.42%-2.41B |
Research and development expenses | -24.97%-8.05B | -16.88%-5.5B | -10.48%-3.51B | -15.92%-1.53B | -43.56%-6.45B | -64.79%-4.71B | -70.99%-3.18B | -45.77%-1.32B | -46.36%-4.49B | -50.73%-2.86B |
Profit from asset sales | -97.95%99.59K | 92.06%-3.66M | 93.16%-2.15M | -113.51%-8.14M | 117.55%4.86M | -229.82%-46.13M | -31.01%-31.48M | 64.88%-3.81M | -201.00%-27.69M | -315.36%-13.99M |
Revaluation surplus | -151.72%-26.04M | -61.42%69.88M | -8.63%-132.42M | 349.78%46.94M | -83.57%50.34M | 7.37%181.12M | -232.89%-121.91M | -309.42%-18.79M | 85.49%306.44M | 2,636.68%168.69M |
-Changes in the fair value of other assets | -151.72%-26.04M | -61.42%69.88M | -8.63%-132.42M | 349.78%46.94M | -83.57%50.34M | 7.37%181.12M | -232.89%-121.91M | -309.42%-18.79M | 85.49%306.44M | 2,636.68%168.69M |
Impairment and provision | -51.62%-550.08M | -270.15%-389.43M | -277.12%-318.59M | -808.59%-178.52M | 38.82%-362.81M | 67.07%-105.21M | 70.46%-84.48M | 226.38%25.19M | 16.68%-593M | 4.95%-319.48M |
-Other impairment is provision | -51.62%-550.08M | -270.15%-389.43M | -277.12%-318.59M | -808.59%-178.52M | 38.82%-362.81M | 67.07%-105.21M | 70.46%-84.48M | 226.38%25.19M | 16.68%-593M | 4.95%-319.48M |
Special items of operating profit | 49.39%2.27B | 23.21%1.36B | 5.79%896.34M | -9.70%409.4M | -29.44%1.52B | -37.94%1.11B | -26.16%847.32M | -31.15%453.39M | 17.01%2.16B | 55.18%1.78B |
Operating profit | 29.13%7.08B | 6.24%5.63B | -57.74%1B | -103.60%-58.66M | -7.45%5.48B | 8.65%5.3B | -33.27%2.37B | -7.61%1.63B | -3.71%5.92B | 39.08%4.88B |
Financing cost | -94.94%125.89M | -110.08%-276.69M | -92.38%223.57M | 95.88%-11.99M | 454.93%2.49B | 587.29%2.74B | 856.93%2.93B | -396.73%-290.83M | 212.93%448.31M | 163.39%399.35M |
Special items of earning before tax | -25.78%623.09M | -67.28%247.08M | -70.36%166.9M | -73.74%132.88M | -24.59%839.55M | 373.88%755.14M | 631.21%563.05M | 1,519.39%506M | 134.05%1.11B | -43.44%159.35M |
Earning before tax | -11.16%7.82B | -36.35%5.6B | -76.27%1.39B | -96.63%62.22M | 17.70%8.81B | 61.85%8.8B | 49.05%5.87B | -2.56%1.85B | 20.15%7.48B | 72.10%5.44B |
Tax | -44.69%-801.24M | 7.20%-604.98M | 89.20%-29.6M | 152.76%113.42M | 26.86%-553.74M | -32.31%-651.89M | 32.65%-274.2M | 15.97%-214.97M | 12.45%-757.09M | 13.93%-492.69M |
After-tax profit from continuing operations | -14.90%7.02B | -38.68%5B | -75.63%1.36B | -89.24%175.64M | 22.72%8.25B | 64.80%8.15B | 58.47%5.59B | -0.46%1.63B | 25.41%6.73B | 91.13%4.94B |
Earning after tax | -14.90%7.02B | -38.68%5B | -75.63%1.36B | -89.24%175.64M | 22.72%8.25B | 64.80%8.15B | 58.47%5.59B | -0.46%1.63B | 25.41%6.73B | 91.13%4.94B |
Minority profit | 109.47%1.25M | 120.74%2.35M | 116.01%1.38M | 168.66%1.41M | -1,126.11%-13.23M | ---11.34M | ---8.62M | ---2.05M | ---1.08M | ---- |
Profit attributable to shareholders | -15.06%7.02B | -38.79%4.99B | -75.69%1.36B | -89.34%174.23M | 22.90%8.27B | 65.03%8.16B | 58.72%5.6B | -0.34%1.63B | 25.43%6.73B | 91.13%4.94B |
Basic earnings per share | -9.89%0.82 | -33.71%0.59 | -73.77%0.16 | -88.89%0.02 | 24.66%0.91 | 64.81%0.89 | 56.41%0.61 | 0.00%0.18 | 23.73%0.73 | 92.86%0.54 |
Diluted earnings per share | -9.89%0.82 | -32.95%0.59 | -73.33%0.16 | -88.89%0.02 | 24.66%0.91 | 62.96%0.88 | 57.89%0.6 | 0.00%0.18 | 25.86%0.73 | 92.86%0.54 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Certified Public Accountants Limited | -- | -- | -- | Deloitte & Touche Certified Public Accountants Limited | -- | -- | -- | Deloitte & Touche Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data